ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)已经完成了对Alimera Sciences, Inc.的收购,这一举措显著扩大了其眼科产品组合。该交易于周一完成,ANI Pharmaceuticals作为母公司,将Alimera吸收为全资子公司。 根据协议条款,Alimera的股东将获得每股5.50美元的现金,外加一个或有价值权(CVR)。如果ILUVIEN®和YU ...

The acquisition strengthens the company’s rare disease segment, and adds 2 durable commercial assets, Iluvien and Yutiq with ...

In a report released today, Oren Livnat from H.C. Wainwright reiterated a Buy rating on ANI Pharmaceuticals (ANIP – Research Report), ...

ANI Pharmaceuticals (ANIP)  said it completed its planned acquisition of Alimera Sciences (NASDAQ:ALIM). Under the terms of ...

Strengthens Rare Disease segment as largest driver of future growth, adding approximately $105 million in 2024 revenue on a ...

PRINCETON, N.J., Sept. 16, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: ANIP) (“ANI” or the “Company”) announced today that the Company ...

ANI Pharmaceuticals, Inc. ("ANI" or "the Company") (Nasdaq: ANIP) today provided an update on the status of the completion of its previously announced ...

Dr Shah Nawaz is the second blasphemy suspect to be shot dead by police in the space of a week. The venue for England’s second Test in Pakistan is switched less than two weeks before the series ...

ANI Pharmaceuticals (ANIP) dropped 4.3% after Truist downgraded shares due to delays in the acquisition of Alimera Sciences, ...

ANI Pharmaceuticals acquiring Alimera Sciences for $5.50 per share with potential for $0.50 per share CVR, offering an ...

Chengdu InSiGa Semiconductor Technologies Co., Ltd. ("InSiGa") and POET Technologies Inc. ("POET") , today announced that they have developed and will showcase in a live demonstration the combination ...

Zoomcar, Zoomcar Holdings, Inc. ("Zoomcar" or the "Company") , the NASDAQ-listed leading marketplace for self-drive car sharing, is thrilled to announce its partnership with Mappls MapmyIndia, India's ...